◆ 会议时间：2026年5月6-8日
◆ 会议地点：德国 柏林
◆ 会议简介：
2026年欧洲肿瘤内科学会(ESMO)乳腺癌年会/大会将于2026年5月6-8日在德国柏林举行。ESMO乳腺癌年会是在欧洲举行的一个多学科全球会议，由全球公认的一流专家参与，是所有对创新、转化肿瘤学和护理感兴趣的乳腺癌研究人员和临床医生的进行交流的平台，预计有超过800名专业人士出席会议。
欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过23,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到宣发展与进步。作为一个非营利组织，ESMO一直以推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.
ESMO BREAST CANCER ANNUAL CONGRESS 2025
Date:
6 - 8 May 2026
Venue:
Berlin, Germany
Organized by:
European Society for Medical Oncology (ESMO)
Join the global breast cancer community in Berlin, Germany, from 6 to 8 May 2026 or online for a specialised event dedicated to advancing the care and treatment of patients worldwide.
This international congress will bring together leading experts, researchers, and clinicians to examine the latest breakthroughs in breast cancer across the entire care continuum—from early detection to treatment innovations and long-term survivorship.
Explore the most up-to-date science in breast cancer diagnosis and treatment strategies, collaborate with global experts to share real-world experiences and help us build the future of breast cancer care.
Scientific Committee Co-Chairs
摘要征文投稿：
Abstract submission deadlines
Abstracts |
Deadline |
Abstracts
Trial in Progress
Intent to submit LBA |
Tuesday, 27 January 2026, 21:00 CET (Central European Time) |
| Late-breaking abstracts (LBA) |
Tuesday, 31 March 2026, 21:00 CEST (Central European Summer Time)
A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline 27 January 2026. |
ESMO Breast Cancer 2026 Abstract regulations
Outcome notifications
Outcome notifications of regular abstracts are expected to be made available to first authors and submitters by end-February 2026.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by early-April 2026.
Detailed instructions for the preparation of slide presentations and/or posters will be made available by end-February in the section “Information for Presenters”.
Abstract presenter registration
Registration is mandatory for all accepted presentation formats, including ePoster. The presenting author or the designated replacement presenter must be registered by 15 April 2026. Should the Presenter (or designated replacement presenter) not be registered by the given deadline, the abstract will be excluded from presentation in the ESMO Breast Cancer 2026 programme and removed from the online programme and publication in the ESMO Breast Cancer 2026 Abstract Book.
Abstract submission categories
- Biomarkers and translational research and precision medicine
- Early breast cancer: Surgery and radiotherapy
- Early breast cancer: Systemic treatments
- Early detection, hereditary breast cancer and prevention
- Metastatic breast cancer
- Supportive care and survivorship
- Miscellaneous
Late-breaking abstracts
Late-breaking abstracts may be submitted for high quality, new research findings with implications for clinical practice or understanding of disease processes.
The final late-breaking abstract deadline of 31 March 2026 is under no circumstances to be considered as an extension of the general submission deadline (27 January 2026).
Trial in Progress abstracts
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ESMO Breast Cancer 2026.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.
Presentation and publication of accepted abstracts
The Breast Cancer 2026 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Paper poster presentation for review and discussion onsite. Presenting authors must attend the Congress in person to represent their work. Preparation of an e-Poster file is also mandatory for inclusion in the Congress Virtual Platform and onsite digital screens.
- e-Poster - Electronic poster in PDF format for inclusion in the Congress Virtual Platform. Presenting authors of e-Posters are not required to attend the Congress in person to represent their work. Paper posters are not to be prepared, and poster boards will not be provided.
All accepted abstracts, including Late-breaking, will be published online in the ESMO Breast Cancer 2026 Abstract Book, a supplement to the official ESMO journal, ESMO Open.
Publication schedule of accepted abstracts
Abstracts accepted for presentation during the ESMO Breast Cancer 2026 will be released online according to a schedule which will be available on the ESMO website in due course.
ESMO Merit Awards
A restricted number of ESMO Merit Awards to the ESMO Breast Cancer 2026 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40 and indicate that they wish to be considered for a Merit Award at the time of submitting the abstract. The selection will be made by the ESMO Breast Cancer 2026 Scientific Committee on a competitive basis from among the accepted abstracts.
ESMO BC 2026 注册费：
Registration includes:
- Participation in scientific and educational sessions
- Opportunities to network with speakers, faculty and peers
- Access to the poster and e-Poster area
- Interaction with the industry partners in the exhibition area
- Participation in the Industry Satellite Symposia
- Live-streamed sessions and sessions on-demand on the virtual congress platform
- Access to the meeting resources on OncologyPRO after the event
- The ESMO Daily Reporter
- Coffee breaks
Registration fees and deadlines
Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.
ESMO membership must be active ten (10) working days prior to the registration, to be eligible for the reduced member registration fee. Please visit membership page on esmo.org to check eligibility criteria, benefits, and complete the membership application.
Registration fees
(19% German VAT included) |
Early registration
until 26 February 2026 |
Late registration
until 8 April 2026 |
Full registration
from 9 April 2026 |
| ESMO Member |
€ 345.00 |
€ 485.00 |
€ 725.00 |
| ESMO Member Developing Countries* |
€ 150.00 |
€ 180.00 |
€ 360.00 |
| ESMO Member in Training** |
€ 150.00 |
€ 180.00 |
€ 230.00 |
| ESMO Member Undergraduate Student |
€ 90.00 |
€ 120.00 |
€ 170.00 |
| ESMO Member Nurse |
€ 130.00 |
€ 160.00 |
€ 200.00 |
| ESMO Member Patient Advocate |
€ 90.00 |
€ 120.00 |
€ 170.00 |
| Non-Member Academia & Other (non Industry)*** |
€ 555.00 |
€ 765.00 |
€ 930.00 |
| Non-Member Industry**** |
€ 665.00 |
€ 885.00 |
€ 1,040.00 |
*Applicable to ESMO members from developing countries only.
At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO members must be under 40 and in training to qualify for this fee.
*** Applicable to individuals working in: Hospitals, Universities, CRO's, Private Practice, Labs, NGO’s, Non-profits, Cancer Patient Advocacy Groups and Gov't Agencies.
**** Applicable to individuals working in: Pharmaceutical / Biotechnology Companies, Service Providers, Consultancies, Financial Institutions, Marketing & Communications Companies, Management & Data Companies and Training & Education Companies.
Other registration fees
(19% German VAT included) |
Fee |
Access |
Exhibition visitor badge
Private meeting badge
Industry satellite badge |
€ 120.00 |
- Exhibition area
- Industry satellite area
- Private meeting area
|
| Third Party Media |
€ 300.00 |
- Venue common areas
- Filming area
- Exhibition area and Private meeting rooms upon invitation only
|
Please send an email to registration@esmo.org to request one of the badges in the "Other registration fees" table above. Kindly note, access to the sessions, virtual congress platform and webcasts are not included.
◆ 参会对象：
肿瘤科医师、乳腺外科医师，妇科医师，乳腺科医师，胸外科医师，普外科医师，介入放射科医师，病理科医师，护士以及从事肿瘤护理与研究的其他相关专业人士等。
|
